This Week In Huntington's Disease Research keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

August, 2018

HD Featured in Science Magazine

Posted on August 30, 2018

The prestigious Science magazine published an article on Huntington’s disease this week, describing the huntingtin-lowering ASO drug developed by Ionis,…

Read More

Proposal to Streamline Gene Therapy Evaluation by the FDA

Posted on August 23, 2018

This week, the FDA released a proposal to streamline the way they oversee the evaluation of protocols related to gene…

Read More

First Gene-Silencing Drug Approved by the FDA

Posted on August 16, 2018

This week marked the first FDA approval of a gene silencing drug, for a rare hereditary disease called ATTR amyloidosis….

Read More

Roche Huntingtin-Lowering Drug Gains PRIME Status from EMA

Posted on August 7, 2018

On August 4th, Roche Pharmaceuticals announced that their huntingtin-lowering therapy was granted PRIME status from the European Medicines Agency (EMA)….

Read More

Voice Your Opinions About The Future Of CRISPR

Posted on August 2, 2018

Community research surveys are valuable ways for researchers to get input from HD patients, families and caregivers about a variety…

Read More